MeSH term
Frequency | Condition_Probility | Cell Differentiation | 3 | 0.0 |
DNA-Binding Proteins/genetics/metabolism | 2 | 0.0 |
Female | 3 | 0.0 |
Gene Expression Profiling | 2 | 0.0 |
Humans | 13 | 0.0 |
Male | 4 | 0.0 |
Metalloproteins/genetics/metabolism | 2 | 33.0 |
*Proto-Oncogene Proteins | 2 | 0.0 |
Research Support, Non-U.S. Gov't | 11 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 9 | 0.0 |
Survival Rate | 2 | 0.0 |
Adult | 2 | 0.0 |
Base Sequence | 5 | 0.0 |
Flow Cytometry | 2 | 0.0 |
Animals | 8 | 0.0 |
Cloning, Molecular | 3 | 0.0 |
Comparative Study | 3 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Mice | 8 | 0.0 |
*Oncogene Proteins | 6 | 9.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Mice, Transgenic | 2 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Homeodomain Proteins/*genetics | 2 | 0.0 |
Mice, Inbred C57BL | 2 | 0.0 |
Molecular Sequence Data | 6 | 0.0 |
Sequence Alignment | 4 | 0.0 |
Transcription Factors/*genetics | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Tumor Cells, Cultured | 3 | 0.0 |
Leukemia, T-Cell, Acute/*genetics | 4 | 10.0 |
Sequence Homology, Amino Acid | 2 | 0.0 |
*Embryonic and Fetal Development | 2 | 1.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Exons | 2 | 0.0 |
Oncogene Proteins/*genetics/metabolism | 2 | 9.0 |
Reverse Transcriptase Polymerase Chain Reaction | 2 | 0.0 |
Oncogenes | 2 | 0.0 |
